Shares surge in the public market debuts of Livongo and Health Catalyst
Both Livongo and Health Catalyst held their IPOs today and saw their stock price soar more than 40 percent in early trading.
Aurinia rocks the boat with $150M public offering
Aurinia Pharmaceuticals put cashflow issues behind it on Tuesday, announcing a public offering that it expects will generate $150.5 million in gross proceeds for its Phase 3 trial in lupus nephritis. But not everyone was happy with the news.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.